Carta
A Novel Use Of Thromboelastography In Type 2b Von Willebrand Disease
Registro en:
International Journal Of Laboratory Hematology. , v. 35, n. 6, p. e11 - e14, 2013.
17515521
10.1111/ijlh.12095
2-s2.0-84887674765
Autor
Toukh M.
Ozelo M.C.
Angelillo-Scherrer A.
Othman M.
Institución
Resumen
[No abstract available] 35 6 e11 e14 Hampshire, D.J., Goodeve, A.C., The international society on thrombosis and haematosis von Willebrand disease database: an update (2011) Semin Thromb Hemost, 37, pp. 470-479 Von Willebrand disease mutation database, , http://www.vwf.group.shef.ac.uk/, Accessed 23 October 2011 Othman, M., Favaloro, E.J., Genetics of type 2B von Willebrand disease: "true 2B", "tricky 2B", or "not 2B". What are the modifiers of the phenotype? (2008) Semin Thromb Hemost, 34, pp. 520-531 Nurden, P., Debili, N., Vainchenker, W., Bobe, R., Bredoux, R., Corvazier, E., Combrie, R., Enouf, J., Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia (2006) Blood, 108, pp. 2587-2595 Federici, A.B., Mannucci, P.M., Stabile, F., Canciani, M.T., Di Rocco, N., Miyata, S., Ware, J., Ruggeri, Z.M., A type 2b von Willebrand disease mutation (Ile546->Val) associated with an unusual phenotype (1997) Thromb Haemost, 78, pp. 1132-1137 Takimoto, Y., Imanaka, F., Type 2B Hiroshima: a variant of von Willebrand disease characterized by chronic thrombocytopenia and the presence of all von Willebrand factor multimers in plasma (1999) Int J Hematol, 70, pp. 127-131 Castaman, G., Eikenboom, J.C., ABO blood group also influences the von Willebrand factor (VWF) antigen level in heterozygous carriers of VWF null alleles, type 2N mutation Arg854GIn, and the missense mutation Cys2362Phe (2002) Blood, 100, pp. 1927-1928 Yuan, Z.H., Zhao, J., Zhang, Y., Zhu, P., [Impact of vWF gene A1381T polymorphism and ABO blood group on von Willebrand factor level in plasma] (2010) Zhongguo Shi Yan Xue Ye Xue Za Zhi, 18, pp. 967-971 Fleming, A.F., Ethnic variation in von Willebrand factor levels can influence the diagnosis of von Willebrand disease (2003) Clin Lab Haematol, 25, p. 413 Miesbach, W., Berntorp, E., When von Willebrand disease comes into age - a matter of change? (2011) Eur J Haematol, 86, pp. 496-501 Ruggeri, Z.M., Mannucci, P.M., Lombardi, R., Federici, A.B., Zimmerman, T.S., Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes (1982) Blood, 59, pp. 1272-1278 Nichols, W.L., Hultin, M.B., James, A.H., Manco-Johnson, M.J., Montgomery, R.R., Ortel, T.L., Add Rick, M.E., Yawn, B.P., von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) (2008) Haemophilia, 14, pp. 171-232 Chen, A., Teruya, J., Global hemostasis testing thromboelastography: old technology, new applications (2009) Clin Lab Med, 29, pp. 391-407 Stammers, A.H., Bruda, N.L., Gonano, C., Hartmann, T., Point-of-care coagulation monitoring: applications of the thromboelastography (1998) Anaesthesia, 53 (SUPPL. 2), pp. 58-59 Chitlur, M., Sorensen, B., Rivard, G.E., Young, G., Ingerslev, J., Othman, M., Nugent, D., Lusher, J., Standardization of thromboelastography: a report from the TEG-ROTEM working group (2011) Haemophilia, 17, pp. 532-537 Chitlur, M., Lusher, J., Standardization of thromboelastography: values and challenges (2010) Semin Thromb Hemost, 36, pp. 707-711 Topf, H.G., Weiss, D., Lischetzki, G., Strasser, E., Rascher, W., Rauh, M., Evaluation of a modified thromboelastography assay for the screening of von Willebrand disease (2011) Thromb Haemost, 105, pp. 1091-1099